Liver Disease in Pregnancy

Clinics in Liver Disease

Volumn 16, Issue 2, 2012, Pages 247-269

  Mufti, Arjmand R ^a   Reau, Nancy ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Liver biochemical profile; Liver disease; Pregnancy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ALPHA GLOBULIN; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BETA GLOBULIN; BILE ACID; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CERULOPLASMIN; CHOLESTEROL; CYCLOSPORIN; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; IMMUNOGLOBULIN; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OCTREOTIDE; PENICILLAMINE; PREDNISONE; SERUM ALBUMIN; TACROLIMUS; TRIACYLGLYCEROL; TRIENTINE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; ZINC ACETATE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIVIRAL THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILE ACID BLOOD LEVEL; BUDD CHIARI SYNDROME; CERULOPLASMIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; COPPER BLOOD LEVEL; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG SAFETY; DRUG USE; ECHOGRAPHY; ECLAMPSIA AND PREECLAMPSIA; FATTY LIVER; FETUS OUTCOME; FIBRINOGEN BLOOD LEVEL; GALLSTONE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GESTATIONAL AGE; HELLP SYNDROME; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; HYPEREMESIS GRAVIDARUM; IMMUNOSUPPRESSIVE TREATMENT; INTRAHEPATIC CHOLESTASIS; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FATTY DEGENERATION; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RADIOGRAPHY; REVIEW; SEPSIS; THIRD TRIMESTER PREGNANCY; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOPLASTIN TIME; TOXIC HEPATITIS; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS HEPATITIS; VIRUS TRANSMISSION; WILSON DISEASE;

FEMALE; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84860280832     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2012.03.011     Document Type: Review

References (147)

1. Ch'ng C.L., Morgan M., Hainsworth I., et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002, 51(6):876-880.
2. Kerr M.G., Scott D.B., Samuel E. Studies of the inferior vena cava in late pregnancy. Br Med J 1964, 1(5382):522.4-533.4.
3. Van Thiel D.H., Gavaler J.S. Pregnancy-associated sex steroids and their effects on the liver. Semin Liver Dis 1987, 7(1):1-7.
4. Bacq Y., Zarka O., Brechot J.F., et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996, 23(5):1030-1034.
5. Girling J.C., Dow E., Smith J.H. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997, 104(2):246-250.
6. Valenzuela G.J., Munson L.A., Tarbaux N.M., et al. Time-dependent changes in bone, placental, intestinal, and hepatic alkaline phosphatase activities in serum during human pregnancy. Clin Chem 1987, 33(10):1801-1806.
7. Darmady J.M., Postle A.D. Lipid metabolism in pregnancy. Br J Obstet Gynaecol 1982, 89(3):211-215.
8. ACOG Committee on Obstetric Practice ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004, 104(3):647-651.
9. De Santis M., Cesari E., Nobili E., et al. Radiation effects on development. Birth Defects Res C Embryo Today 2007, 81(3):177-182.
10. Bashiri A., Neumann L., Maymon E., et al. Hyperemesis gravidarum: epidemiologic features, complications and outcome. Eur J Obstet Gynecol Reprod Biol 1995, 63(2):135-138.
11. Goodwin T.M. Hyperemesis gravidarum. Obstet Gynecol Clin North Am 2008, 35(3):401-417. viii.
12. Goodwin T.M. Hyperemesis gravidarum. Clin Obstet Gynecol 1998, 41(3):597-605.
13. Verberg M.F., Gillott D.J., Al-Fardan N., et al. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005, 11(5):527-539.
14. Bottomley C., Bourne T. Management strategies for hyperemesis. Best practice & research. Clin Obstet Gynaecol 2009, 23(4):549-564.
15. Gadsby R., Barnie-Adshead A.M., Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 1993, 43(371):245-248.
16. Tsang I.S., Katz V.L., Wells S.D. Maternal and fetal outcomes in hyperemesis gravidarum. Int J Gynaecol Obstet 1996, 55(3):231-235.
17. Kaplan P.B., Gucer F., Sayin N.C., et al. Maternal serum cytokine levels in women with hyperemesis gravidarum in the first trimester of pregnancy. Fertil Steril 2003, 79(3):498-502.
18. Leylek O.A., Toyaksi M., Erselcan T., et al. Immunologic and biochemical factors in hyperemesis gravidarum with or without hyperthyroxinemia. Gynecol Obstet Invest 1999, 47(4):229-234.
19. Minagawa M., Narita J., Tada T., et al. Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell Immunol 1999, 196(1):1-13.
20. Taskin S., Taskin E.A., Seval M.M., et al. Serum levels of adenosine deaminase and pregnancy-related hormones in hyperemesis gravidarum. J Perinat Med 2009, 37(1):32-35.
21. Colin J.F., Mathurin P., Durand F., et al. Gastroenterol Clin Biol 1994, 18(4):378-380. [in French].
22. Goodwin T.M., Montoro M., Mestman J.H. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992, 167(3):648-652.
23. Hepburn I.S., Schade R.R. Pregnancy-associated liver disorders. Dig Dis Sci 2008, 53(9):2334-2358.
24. Conchillo J.M., Pijnenborg J.M., Peeters P., et al. Liver enzyme elevation induced by hyperemesis gravidarum: aetiology, diagnosis and treatment. Neth J Med 2002, 60(9):374-378.
25. Kuscu N.K., Koyuncu F. Hyperemesis gravidarum: current concepts and management. Postgrad Med J 2002, 78(916):76-79.
26. Hay J.E. Liver disease in pregnancy. Hepatology 2008, 47(3):1067-1076.
27. Su G.L. Pregnancy and liver disease. Curr Gastroenterol Rep 2008, 10(1):15-21.
28. Nageotte M.P., Briggs G.G., Towers C.V., et al. Droperidol and diphenhydramine in the management of hyperemesis gravidarum. Am J Obstet Gynecol 1996, 174(6):1801-1805. [discussion: 1805-6].
29. Seto A., Einarson T., Koren G. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol 1997, 14(3):119-124.
30. Reyes H., Gonzalez M.C., Ribalta J., et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med 1978, 88(4):487-493.
31. Ribalta J., Reyes H., Gonzalez M.C., et al. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology 1991, 13(6):1084-1089.
32. Rioseco A.J., Ivankovic M.B., Manzur A., et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994, 170(3):890-895.
33. Laifer S.A., Stiller R.J., Siddiqui D.S., et al. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 2001, 10(2):131-135.
34. Lee R.H., Goodwin T.M., Greenspoon J., et al. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 2006, 26(9):527-532.
35. Schneider G., Paus T.C., Kullak-Ublick G.A., et al. Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology 2007, 45(1):150-158.
36. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997, 12(3):211-216.
37. Ropponen A., Sund R., Riikonen S., et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006, 43(4):723-728.
38. Fisk N.M., Bye W.B., Storey G.N. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital. Aust N Z J Obstet Gynaecol 1988, 28(3):172-176.
39. Bacq Y., Sapey T., Brechot M.C., et al. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997, 26(2):358-364.
40. Glantz A., Marschall H.U., Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004, 40(2):467-474.
41. Turunen K., Sumanen M., Haukilahti R.L., et al. Good pregnancy outcome despite intrahepatic cholestasis. Scand J Prim Health Care 2010, 28(2):102-107.
42. Arrese M., Macias R.I., Briz O., et al. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Mol Med 2008, 10:e9.
43. Dixon P.H., van Mil S.W., Chambers J., et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009, 58(4):537-544.
44. Eloranta M.L., Hakli T., Hiltunen M., et al. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand J Gastroenterol 2003, 38(6):648-652.
45. Floreani A., Carderi I., Paternoster D., et al. Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. Dig Liver Dis 2008, 40(5):366-370.
46. Mullenbach R., Bennett A., Tetlow N., et al. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 2005, 54(6):829-834.
47. Oude Elferink R.P., Paulusma C.C. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch 2007, 453(5):601-610.
48. Day C., Hewins P., Sheikh L., et al. Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients. Transpl Int 2006, 19(12):1026-1029.
49. Dann A.T., Kenyon A.P., Seed P.T., et al. Glutathione S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology 2004, 40(6):1406-1414.
50. Reyes H., Baez M.E., Gonzalez M.C., et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 2000, 32(4):542-549.
51. Glantz A., Marschall H.U., Lammert F., et al. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005, 42(6):1399-1405.
52. Knox T.A., Olans L.B. Liver disease in pregnancy. N Engl J Med 1996, 335(8):569-576.
53. Rolfes D.B., Ishak K.G. Liver disease in pregnancy. Histopathology 1986, 10(6):555-570.
54. Mazzella G., Rizzo N., Azzaroli F., et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001, 33(3):504-508.
55. Zapata R., Sandoval L., Palma J., et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int 2005, 25(3):548-554.
56. Kondrackiene J., Beuers U., Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005, 129(3):894-901.
57. Roncaglia N., Locatelli A., Arreghini A., et al. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. BJOG 2004, 111(1):17-21.
58. Barton J.R., Sibai B.M. Gastrointestinal complications of pre-eclampsia. Semin Perinatol 2009, 33(3):179-188.
59. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365(9461):785-799.
60. Lindheimer M.D., Taler S.J., Cunningham F.G. Hypertension in pregnancy. J Am Soc Hypertens 2008, 2(6):484-494.
61. Pritchard J.A., Weisman R., Ratnoff O.D., et al. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med 1954, 250(3):89-98.
62. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142(2):159-167.
63. Barton J.R., Sibai B.M. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004, 31(4):807-833. vii.
64. Baxter J.K., Weinstein L. HELLP syndrome: the state of the art. Obstet Gynecol Surv 2004, 59(12):838-845.
65. Sibai B.M., Ramadan M.K., Usta I., et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993, 169(4):1000-1006.
66. Egerman R.S., Sibai B.M. HELLP syndrome. Clin Obstet Gynecol 1999, 42(2):381-389.
67. Benjaminov F.S., Heathcote J. Liver disease in pregnancy. Am J Gastroenterol 2004, 99(12):2479-2488.
68. Martin J.N., Rose C.H., Briery C.M. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006, 195(4):914-934.
69. Mihu D., Costin N., Mihu C.M., et al. HELLP syndrome-a multisystemic disorder. J Gastrointestin Liver Dis 2007, 16(4):419-424.
70. Shames B.D., Fernandez L.A., Sollinger H.W., et al. Liver transplantation for HELLP syndrome. Liver Transpl 2005, 11(2):224-228.
71. van Runnard Heimel P.J., Franx A., Schobben A.F., et al. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv 2005, 60(1):57-70. [quiz: 73-4].
72. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004, 103(5 Pt 1):981-991.
73. Zarrinpar A., Farmer D.G., Ghobrial R.M., et al. Liver transplantation for HELLP syndrome. Am Surg 2007, 73(10):1013-1016.
74. Sibai B.M., Ramadan M.K., Chari R.S., et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995, 172(1 Pt 1):125-129.
75. Bacq Y., Riely C.A. Acute fatty liver of pregnancy: the hepatologist's view. Gastroenterologist 1993, 1(4):257-264.
76. Fesenmeier M.F., Coppage K.H., Lambers D.S., et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol 2005, 192(5):1416-1419.
77. Browning M.F., Levy H.L., Wilkins-Haug L.E., et al. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006, 107(1):115-120.
78. Reyes H., Sandoval L., Wainstein A., et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut 1994, 35(1):101-106.
79. Knight M., Nelson-Piercy C., Kurinczuk J.J., et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008, 57(7):951-956.
80. Schoeman M.N., Batey R.G., Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology 1991, 100(2):544-548.
81. Treem W.R., Rinaldo P., Hale D.E., et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994, 19(2):339-345.
82. Wilcken B., Leung K.C., Hammond J., et al. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 1993, 341(8842):407-408.
83. Treem W.R., Shoup M.E., Hale D.E., et al. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Gastroenterol 1996, 91(11):2293-2300.
84. Yang Z., Zhao Y., Bennett M.J., et al. Fetal genotypes and pregnancy outcomes in 35 families with mitochondrial trifunctional protein mutations. Am J Obstet Gynecol 2002, 187(3):715-720.
85. Ibdah J.A., Bennett M.J., Rinaldo P., et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999, 340(22):1723-1731.
86. Visconti M., Manes G., Giannattasio F., et al. Recurrence of acute fatty liver of pregnancy. J Clin Gastroenterol 1995, 21(3):243-245.
87. MacLean M.A., Cameron A.D., Cumming G.P., et al. Recurrence of acute fatty liver of pregnancy. Br J Obstet Gynaecol 1994, 101(5):453-454.
88. Goldstein S.T., Zhou F., Hadler S.C., et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34(6):1329-1339.
89. Castro M.A., Fassett M.J., Reynolds T.B., et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999, 181(2):389-395.
90. Ibdah J.A. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006, 12(46):7397-7404.
91. McMahon B.J., Alward W.L., Hall D.B., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985, 151(4):599-603.
92. Xu D.Z., Yan Y.P., Choi B.C., et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002, 67(1):20-26.
93. Alter M.J. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003, 39(Suppl 1):S64-S69.
94. Burk R.D., Hwang L.Y., Ho G.Y., et al. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994, 170(6):1418-1423.
95. Noto H., Terao T., Ryou S., et al. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994. J Gastroenterol Hepatol 2003, 18(8):943-949.
96. Han G.R., Cao M.K., Zhao W., et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011, 55(6):1215-1221.
97. Shi Z., Yang Y., Ma L., et al. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 2010, 116(1):147-159.
98. Gartner L.M., Morton J., Lawrence R.A., et al. Breastfeeding and the use of human milk. Pediatrics 2005, 115(2):496-506.
99. Englert Y., Lesage B., Van Vooren J.P., et al. Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update 2004, 10(2):149-162.
100. Alter M.J., Kruszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999, 341(8):556-562.
101. Costa Z.B., Machado G.C., Avelino M.M., et al. Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect Dis 2009, 9:116.
102. Schwimmer J.B., Balistreri W.F. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Semin Liver Dis 2000, 20(1):37-46.
103. Conte D., Fraquelli M., Prati D., et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000, 31(3):751-755.
104. Mast E.E., Hwang L.Y., Seto D.S., et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005, 192(11):1880-1889.
105. Pergam S.A., Wang C.C., Gardella C.M., et al. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol 2008, 199(1):38.e1-38.e9.
106. Ghamar Chehreh M.E., Tabatabaei S.V., Khazanehdari S., et al. Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis. Arch Gynecol Obstet 2011, 283(2):255-260.
107. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998, 47(RR-19):1-39.
108. Aggarwal N., Sawnhey H., Suril V., et al. Pregnancy and cirrhosis of the liver. Aust N Z J Obstet Gynaecol 1999, 39(4):503-506.
109. Russell M.A., Craigo S.D. Cirrhosis and portal hypertension in pregnancy. Semin Perinatol 1998, 22(2):156-165.
110. Steven M.M. Pregnancy and liver disease. Gut 1981, 22(7):592-614.
111. Steven M.M., Mackay I.R. Prognosis of pregnancy in chronic liver disease. Gastroenterology 1980, 78(5 Pt 1):1116-1117.
112. Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 2006, 55(8):1198-1206.
113. Candia L., Marquez J., Espinoza L.R. Autoimmune hepatitis and pregnancy: a rheumatologist's dilemma. Semin Arthritis Rheum 2005, 35(1):49-56.
114. Heneghan M.A., Norris S.M., O'Grady J.G., et al. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001, 48(1):97-102.
115. Schramm C., Herkel J., Beuers U., et al. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006, 101(3):556-560.
116. Manns M.P., Czaja A.J., Gorham J.D., et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010, 51(6):2193-2213.
117. Gossard A.A., Lindor K.D. Pregnancy in a patient with primary sclerosing cholangitis. J Clin Gastroenterol 2002, 35(4):353-355.
118. Poupon R., Chretien Y., Chazouilleres O., et al. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. J Hepatol 2005, 42(3):418-419.
119. Lindor K.D., Gershwin M.E., Poupon R., et al. Primary biliary cirrhosis. Hepatology 2009, 50(1):291-308.
120. Wellge B.E., Sterneck M., Teufel A., et al. Pregnancy in primary sclerosing cholangitis. Gut 2011, 60(8):1117-1121.
121. Compston A. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912:34;295-509. Brain 2009, 132(Pt 8):1997-2001.
122. Brewer G.J., Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992, 71(3):139-164.
123. Mak C.M., Lam C.W. Diagnosis of Wilson's disease: a comprehensive review. Crit Rev Clin Lab Sci 2008, 45(3):263-290.
124. Brewer G.J., Johnson V.D., Dick R.D., et al. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy. Hepatology 2000, 31(2):364-370.
125. Walshe J.M. The management of pregnancy in Wilson's disease treated with trientine. QJM 1986, 58(225):81-87.
126. Roberts E.A., Schilsky M.L. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008, 47(6):2089-2111.
127. Fiore S., Savasi V. Treatment of viral hepatitis in pregnancy. Expert Opin Pharmacother 2009, 10(17):2801-2809.
128. Devarbhavi H., Kremers W.K., Dierkhising R., et al. Pregnancy-associated acute liver disease and acute viral hepatitis: differentiation, course and outcome. J Hepatol 2008, 49(6):930-935.
129. Clemente-Casares P., Pina S., Buti M., et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003, 9(4):448-454.
130. Rein D.B., Stevens G., Theaker J., et al. The global burden of hepatitis E virus. Hepatology 2011, [Epub ahead of print].
131. Aggarwal R. Clinical presentation of hepatitis E. Virus Res 2011, 161(1):15-22.
132. Kumar R.M., Uduman S., Rana S., et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001, 100(1):9-15.
133. Mateos Lindemann M.L., Morales J.G., Fernandez-Barredo S., et al. Fulminant hepatitis E in a woman taking oral contraceptive medication. Am J Trop Med Hyg 2010, 82(1):12-15.
134. Teshale E.H., Hu D.J., Holmberg S.D. The two faces of hepatitis E virus. Clin Infect Dis 2010, 51(3):328-334.
135. Elinav E., Ben-Dov I.Z., Shapira Y., et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 2006, 130(4):1129-1134.
136. Ehsanipoor R.M., Major C.A. Herpes simplex and HIV infections and preterm PROM. Clin Obstet Gynecol 2011, 54(2):330-336.
137. Klein N.A., Mabie W.C., Shaver D.C., et al. Herpes simplex virus hepatitis in pregnancy. Two patients successfully treated with acyclovir. Gastroenterology 1991, 100(1):239-244.
138. Ko C.W., Beresford S.A., Schulte S.J., et al. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 2005, 41(2):359-365.
139. Mendez-Sanchez N., Chavez-Tapia N.C., Uribe M. Pregnancy and gallbladder disease. Ann Hepatol 2006, 5(3):227-230.
140. Khuroo M.S., Datta D.V. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 1980, 68(1):113-121.
141. Rautou P.E., Plessier A., Bernuau J., et al. Pregnancy: a risk factor for Budd-Chiari syndrome?. Gut 2009, 58(4):606-608.
142. Douglas N.C., Shah M., Sauer M.V. Fertility and reproductive disorders in female solid organ transplant recipients. Semin Perinatol 2007, 31(6):332-338.
143. Walcott W.O., Derick D.E., Jolley J.J., et al. Successful pregnancy in a liver transplant patient. Am J Obstet Gynecol 1978, 132(3):340-341.
144. Armenti V.T. Pregnancy after liver transplantation. Liver Transpl 2006, 12(7):1037-1039.
145. Christopher V., Al-Chalabi T., Richardson P.D., et al. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl 2006, 12(7):1138-1143.
146. Jain A.B., Reyes J., Marcos A., et al. Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation 2003, 76(5):827-832.
147. Kainz A., Harabacz I., Cowlrick I.S., et al. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation 2000, 70(12):1718-1721.